Search for: "ACTAVIS"
Results 921 - 940
of 1,010
Sorted by Relevance
|
Sort by Date
17 Nov 2010, 1:48 am
(FDA Law Blog) Crestor (Rosuvastatin) – US: AstraZeneca defeats Teva’s claim that Crestor infringes Teva’s patent (Orange Book Blog) Crestor (Rosuvastatin) – US: AstraZeneca files patent infringement suit against Watson in response to Para IV certification (Patent Docs) Efexor (Venlafaxine) – Australia: Federal Court blocks generic Efexor-XR: Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth Australia Pty Ltd (Patentology) (BAZPAT) (GenericsWeb) Fipronil – UK:… [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs) Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in Maryland and Delaware… [read post]
27 Aug 2008, 11:50 pm
" Will Novartis/Sandoz wait two years to recall the drugs like Actavis did with Digitek? [read post]
22 Dec 2016, 9:10 am
In the event that permission is granted, Actavis and Mylan have applied for permission to cross-appeal the findings on validity in relation to claims 10-12. [read post]
8 May 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs) Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in Maryland and Delaware… [read post]
27 Oct 2010, 3:38 am
General GSK forms alliance for development of gene therapy techniques for rare diseases (Patent Docs) Emerging economies’ new initiative on falsified and substandard medicines (IP Watch) Michèle Rivasi asks question about ACTA and Access to Medicine (KEI) As negotiators launch talks on biodiversity, industry requests IP protection (IP Watch) Negotiators persist on biodiversity benefit-sharing treaty despite slipping deadlines (IP Watch) New draft biodiversity treaty text shows much work… [read post]
3 Apr 2014, 11:30 pm
Actavis, Inc. [read post]
17 Feb 2010, 5:10 am
Actavis Elizabeth LLC, et al. [read post]
29 Jul 2010, 7:04 am
All this led the IPKat to think, perhaps rather egotistically, that his (and some of his readers') words on how the Court of Appeal might have got it wrong in Actavis v Novartis could have had some effect. [read post]
21 Dec 2023, 9:41 am
Actavis Laby’s UT, Inc., 65 F.4th 679, 692 (Fed. [read post]
18 Jun 2020, 3:06 am
AccuDock Actavis, Inc. [read post]
26 May 2019, 2:13 pm
Observations on Geography while Waiting for G2/19 | AIPPI Event Report: Actavis v ICOS Supreme Court Rapid Response | Paul Rawlinson (1962-2019) | Retromark Volume V: the last six months in trade marks | BREAKING: Council adopts DSM Directive | USPTO find two male torso-shaped perfume bottles confusingly similar | Guitar headstock not distinctive for … guitars, says EUIPO Board of Appeal | Conference report - More than Just a Game | What is bad faith? [read post]
19 Jul 2016, 6:54 pm
The AmeriKat on a sleepless summer nightmusing on the future of patent litigationThe late night witching hours have begun again for the AmeriKat. [read post]
7 Aug 2019, 1:42 am
The IPCom guidance are provided for readers' convenience at the end of this post.The IPCom factors have since been applied in Actavis v Pharmacia [2014] EWHC 2265 (stay was ordered), and Eli Lilly v Janssen Sciences [2016] EWHC 313 (stay was not ordered) (IPKat post here).David Stone (sitting as a Deputy High Court Judge), applied the IPCom guidance to the fact of the case in Coloplast v Salts. [read post]
13 Jun 2019, 1:06 pm
Observations on Geography while Waiting for G2/19 | AIPPI Event Report: Actavis v ICOS Supreme Court Rapid Response | Paul Rawlinson (1962-2019) | Retromark Volume V: the last six months in trade marks | BREAKING: Council adopts DSM Directive | USPTO find two male torso-shaped perfume bottles confusingly similar | Guitar headstock not distinctive for … guitars, says EUIPO Board of Appeal | Conference report - More than Just a Game | What is bad faith? [read post]
12 Feb 2016, 1:45 pm
The beginning of the en banc opinion reads:Congress has declared: “Except as otherwise providedin [the Patent Act], whoever without authority makes,uses, offers to sell, or sells any patented invention, withinthe United States or imports into the United States anypatented invention during the term of the patent therefor,infringes the patent. [read post]
25 Sep 2015, 8:17 am
If you think you can get safe harbors, Congress will be the entity to do that after Actavis. [read post]
25 Apr 2014, 1:45 am
"Wim van der Eijk observing howmuch the EPO empire has grownIPKat readers will note that Mr Justice Arnold has followed suit in his recent referrals, the Actavis v Sanofi judgment being one such instance. [read post]
16 Jun 2019, 11:07 am
Observations on Geography while Waiting for G2/19 | AIPPI Event Report: Actavis v ICOS Supreme Court Rapid Response | Paul Rawlinson (1962-2019) | Retromark Volume V: the last six months in trade marks | BREAKING: Council adopts DSM Directive | USPTO find two male torso-shaped perfume bottles confusingly similar | Guitar headstock not distinctive for … guitars, says EUIPO Board of Appeal | Conference report - More than Just a Game | What is bad faith? [read post]
